Hoxton Financial’s Meridian Bioscience Inc VIVO Stock Holding History

Hoxton Financial’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$32K	Hold	1,539	–	–	0.02%	178
2015 Q4	$32K	Hold	1,539	–	–	0.02%	163
2015 Q3	$26K	Hold	1,539	–	–	0.01%	167
2015 Q2	$29K	Hold	1,539	–	–	0.01%	170
2015 Q1	$29K	Hold	1,539	–	–	0.01%	167
2014 Q4	$25K	Hold	1,539	–	–	0.01%	177
2014 Q3	$27K	Hold	1,539	–	–	0.01%	159
2014 Q2	$32K	Hold	1,539	–	–	0.01%	150
2014 Q1	$34K	Hold	1,539	–	–	0.01%	148
2013 Q4	$41K	Hold	1,539	–	–	0.02%	240
2013 Q3	$36K	Hold	1,539	–	–	0.04%	150
2013 Q2	$33K	Buy	+1,539	New	+$33.2K	0.02%	232

Other funds holding VIVO

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Hoxton Financial's VIVO Position: Q1 2016 in Review

Hoxton Financial held its Meridian Bioscience Inc (VIVO) position steady in Q1 2016 at 1,539 shares worth $32K. The position accounts for 0.02% of the portfolio, ranked #178.

Hoxton Financial first reported a position in VIVO in Q2 2013 and has held it in 12 quarters since. The position peaked at $41K in Q4 2013. 172 funds tracked by Wall St. Rank hold VIVO as of Q1 2016.

Hoxton Financial held 1,539 shares of Meridian Bioscience Inc worth $32K as of Q1 2016.
Hoxton Financial left its Meridian Bioscience Inc share count unchanged in Q1 2016.
Meridian Bioscience Inc made up 0.02% of Hoxton Financial's portfolio in Q1 2016, its #178 holding.
Hoxton Financial first reported a position in Meridian Bioscience Inc in Q2 2013 and has held it in 12 quarters since.
Hoxton Financial's Meridian Bioscience Inc position peaked at $41K in Q4 2013.
172 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2016.

Based on Hoxton Financial's 13F filing for Q1 2016, filed 29 Apr 2016.